METADICHOL
DEAD

Serial Number

77808847

Owner

NANORX INC.

First Use Date

Jun 10, 2010

Filing Date

Aug 20, 2009

Add to watchlist:

No watchlists yet
View on USPTO

METADICHOL Trademark

Serial Number: 77808847 • Registration: 3978756

METADICHOL is a trademark filed by NANORX INC. on August 20, 2009. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NANORX INC. (6 trademarks)

6 Devoe Place
Chappaqua, NY 10514

Entity Type: 03

Trademark Details

Filing Date

August 20, 2009

Registration Date

June 14, 2011

First Use Anywhere

June 10, 2010

First Use in Commerce

October 10, 2010

Published for Opposition

January 19, 2010

Cancellation Date

January 19, 2018

Goods & Services

Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of DIABETES; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of HYPERTENSION; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical solutions used in dialysis; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; Therapeutic pharmaceutical for the treatment of OBESITY

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 19, 2018 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 14, 2016 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 13, 2011 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
May 12, 2011 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 12, 2011 CNPR
EXAMINER'S AMENDMENT ENTERED
May 12, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 12, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
May 12, 2011 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
May 12, 2011 SNEA
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
May 11, 2011 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
May 11, 2011 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
May 11, 2011 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2011 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 8, 2011 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 7, 2011 GNFN
FINAL REFUSAL E-MAILED
Apr 7, 2011 GNFR
SU - FINAL REFUSAL - WRITTEN
Apr 7, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2011 CRFA
ASSIGNED TO LIE
Feb 16, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2010 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2010 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 1, 2010 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Nov 4, 2010 SUPC
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Nov 4, 2010 UNTD
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 28, 2010 EPPA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 28, 2010 AITU
USE AMENDMENT FILED
Oct 8, 2010 IUAF
TEAS REQUEST TO DIVIDE RECEIVED
Oct 8, 2010 ERTD
TEAS STATEMENT OF USE RECEIVED
Oct 8, 2010 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Apr 13, 2010 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 19, 2010 NPUB
PUBLISHED FOR OPPOSITION
Jan 19, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 14, 2009 PREV
ASSIGNED TO LIE
Dec 14, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 28, 2009 CNSA
ASSIGNED TO EXAMINER
Nov 24, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2009 NWOS
NEW APPLICATION ENTERED
Aug 24, 2009 NWAP